author-photo

Stefania Mosconi

35

Papers

1598

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program

2018 Oncologist
Show All
- Source
- Cite
- Save
Citations (26)
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial

2018 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (86)
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients

2017 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (20)
D1*Randomized phase 2 trial of peri- or post-operative chemotherapy in resectable pancreatic adenocarcinoma

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (175)
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second‑line therapy in advanced biliary tract adenocarcinoma

2016 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (8)
Open-label, randomized, multicenter, phase II trial designed to compare the efficacy of CAPTEM combination versus FOLFIRI as second line treatment in patients (pts) who have progressed on or after first-line oxaliplatin-containing chemotherapy for advanced, MGMT methylated, RAS mutated colorectal cancer (CRC).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib

2015 Oncotarget
Show All
- Source
- Cite
- Save
Citations (32)
Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

2014 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (34)